
A study examined 105 patients with moderate-to-severe atopic dermatitis treated with upadacitinib. It found that achieving low pruritus levels by week 2 significantly increased the likelihood of complete skin clearance at weeks 12 and 24. Patients with early peak pruritus-numerical rating scale (PP-NRS) ≤ 1 had a much higher rate (42.9%) of achieving EASI 100 at week 24 compared to non-achievers (1.4%). Logistic regression analysis indicated that week 2 PP-NRS ≤ 1 and low body mass index were predictors for EASI 100 at later phases.
Like
Save
Share